Hansa Biopharma: Notice to Annual General Meeting
Lund, Sweden May 30, 2022, Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in Lund, gives notice to Annual General Meeting on Thursday June 30, 2022. The Annual General Meeting in Hansa Biopharma will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties. Hansa Biopharma welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the